Molekule Launches New Alexa Skill Commands for Advanced Device Control
Customers can add the Alexa skill for free with their voice on any Alexa-enabled device via the Alexa app. With a new custom skill around filter status and room-specific air quality insights, Molekule is enabling people to take more control of the air they breathe and easily mitigate poor air quality using Molekule’s proprietary PECO technology with just a few quick phrases.
“According to the
Molekule already offers another Alexa skill, the Molekule Air Quality Review Skill, which provides local outdoor air quality data by using the device's location. With a robust portfolio of commands now available to consumers, device owners can receive critical information about both outdoor and indoor air quality, take necessary precautions, and better protect themselves against dirty air.
“With improved smart home integration and device control, we’re envisioning a world where checking air quality is as easy as checking the weather,” said
The Skill is available for all Air, Air Mini, Air Mini+, and Air Pro devices located in the
- “Turn on/off [device name]”
- “Set [device name] to [desired fan speed 1, 2, or 3]”
- “Set mode of [device name] to standard/silent/quiet”
- “Ask Molekule purifier what is quality of air near [device name]”
- “Ask Molekule purifier to get filter health of [device name]”
For more information, visit here.
About Molekule
Molekule is on a mission to provide clean indoor air to everyone, everywhere. With the largest range of proprietary, FDA-cleared air purification devices on the market, Molekule is providing consumers, business owners, and medical professionals with hardware and software solutions to better understand and improve indoor air quality. Its Air Pro, Air Mini+, and Pūrgo™ purification devices can be applied to virtually any indoor space, including homes, classrooms, offices, hospitals, and more. For more information and customer reviews, visit https://molekule.com.
Media Contacts
Press@molekule.com
Investor Relations Contacts
Ryan.Tyler@molekule.com
molekule@mattio.com
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current beliefs and expectations of our management and are subject to known and unknown risks and uncertainties. Words or expressions such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “may,” “will,” “projects,” “could,” “should,” “would,” “seek,” “forecast,” or other similar expressions help identify forward-looking statements. Factors that could cause actual events to differ include, but are not limited to:
- our total addressable market;
- general economic conditions in the markets where we operate;
- the impact of the COVID-19 pandemic and related prophylactic measures;
- the expected timing of regulatory approvals and product launches;
- non-performance of third-party vendors and contractors;
- risks related to our ability to successfully sell our products and the market reception to and performance of our products;
- our compliance with, and changes to, applicable laws and regulations;
- our limited operating history;
- our ability to manage growth;
- our ability to obtain additional financing when and if needed;
- our ability to expand product offerings;
- our ability to compete with others in our industry;
- our ability to protect our intellectual property;
- the ability of certain existing stockholders to determine the outcome of matters which require stockholder approval;
- our ability to retain the listing of our common stock on Nasdaq;
- our ability to defend against legal proceedings;
- our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
- the ability to successfully integrate the businesses after the completion of the Merger;
- our ability to achieve the expected benefits from the Merger within the expected time frames or at all;
- the incurrence of unexpected costs, liabilities or delays relating to the Merger;
- the risk that the public assigns a lower value to Molekule’s business than the value used in negotiating the terms of the Merger;
- the risk that the Merger may not be accretive to our stockholders;
- the risk that the Merger may prevent us from acting on future opportunities to enhance stockholder value;
- the risk that any goodwill or identifiable intangible assets recorded due to the Merger could become impaired; and
- other economic, business, competitive, and regulatory factors affecting the businesses of the company generally, including but not limited to those set forth in the AeroClean’s filings with the
Securities and Exchange Commission , including in the “Risk Factors” section of AeroClean’s information statement/prospectus filed with theSecurities and Exchange Commission onDecember 21, 2022 , and otherSEC filings.
Forward looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in the forward looking statements as a result of various factors. Although the combined company believes that the expectations reflected in the forward looking statements are reasonable based on information currently available, the combined company cannot assure you that the expectations will prove to have been correct. Accordingly, you should not place undue reliance on these forward looking statements. In any event, these statements speak only as of the date of this release.

Source: Molekule Group, Inc.